ACQ2 by Acquired cover image

The Outsiders Book Club Discussion with author Will Thorndike

ACQ2 by Acquired

00:00

Innovative Strategies and Controversial Compensation in Pharmaceuticals

This chapter explores Valiant's innovative approach under the leadership of a former McKinsey executive, detailing strategies to reduce R&D costs and utilize acquisitions for growth. It also examines a controversial compensation package linked to performance metrics, which played a crucial role in shaping the CEO's decisions and impacting stock performance.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app